NEW YORK – UK-based technology development company RNAssist said this week that it has licensed its VivoPhix biomolecule stabilization technology to Quality Control for Molecular Diagnostics (QCMD).
NEW YORK – UK-based technology development company RNAssist said this week that it has licensed its VivoPhix biomolecule stabilization technology to Quality Control for Molecular Diagnostics (QCMD).
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.